The necessity to increase the efficiency of organ preservation has pushed physicians to consider the use of pharmacological additives in preservation solutions to minimize
ischemia reperfusion injury. Here, we evaluated the effect of
fucoidan, sulfated
polysaccharide from brown seaweed, as an additive to IGL-1 (Institut Georges Lopez) preservation
solution. Livers from Wistar rats were preserved for 24 h at 4 °C in
IGL-1 solution, enriched or not with
fucoidan (100 mg/L). Thereafter, they were subjected to reperfusion (2 h, at 37 °C) using an isolated perfused rat liver model. The addition of
fucoidan to
IGL-1 solution reduced hepatic injury (AST, ALT) and improved liver function compared to
IGL-1 solution without
fucoidan. In addition, we noted a significant increase in the phosphorylation of AMPK, AKT
protein kinase and GSK3-β, leading to a reduction in VDAC phosphorylation, as well as a reduction in apoptosis (
caspase 3), mitochondrial damage, oxidative stress and endoplasmic reticulum (ER) stress markers. Furthermore, ERK1/2 and P38 MAPKs phosphorylation significantly decreased after supplementation of
IGL-1 solution with
fucoidan. In conclusion, the supplementation of
IGL-1 solution with
fucoidan maintained liver graft integrity and function through the prevention of the ER stress, oxidative stress and
mitochondrial dysfunction.
Fucoidan could be considered as potential natural therapeutic agent to alleviate graft injury.